Spots Global Cancer Trial Database for bcg vaccine
Every month we try and update this database with for bcg vaccine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer | NCT00003759 | Bladder Cancer | BCG vaccine valrubicin conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | NCT00016133 | Colorectal Canc... | BCG vaccine autologous tumo... fluorouracil leucovorin calc... adjuvant therap... | 21 Years - 85 Years | National Cancer Institute (NCI) | |
| Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery | NCT00427570 | Colorectal Canc... | BCG vaccine biological ther... fluorouracil semustine vincristine sul... | - 79 Years | National Cancer Institute (NCI) | |
| The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer | NCT01697306 | Bladder Cancer | Gemcitabine 2 g BCG Vaccine | 18 Years - 85 Years | Azienda Ospedaliera San Giovanni Battista | |
| BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer | NCT00004122 | Bladder Cancer | BCG vaccine recombinant int... | 18 Years - | Roswell Park Cancer Institute | |
| Vaccine Therapy in Treating Women With Metastatic Breast Cancer | NCT00003184 | Breast Cancer | BCG vaccine CD80 breast can... sargramostim | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery | NCT00427570 | Colorectal Canc... | BCG vaccine biological ther... fluorouracil semustine vincristine sul... | - 79 Years | National Cancer Institute (NCI) | |
| BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer | NCT00004122 | Bladder Cancer | BCG vaccine recombinant int... | 18 Years - | Roswell Park Cancer Institute | |
| AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer | NCT00003759 | Bladder Cancer | BCG vaccine valrubicin conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer | NCT00352079 | Bladder Cancer | BCG vaccine gefitinib quality-of-life... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma | NCT00003715 | Melanoma (Skin) | BCG vaccine autologous tumo... recombinant int... chemotherapy cyclophosphamid... | 18 Years - 120 Years | AVAX Technologies | |
| BCG With or Without Mitomycin in Treating Patients With Bladder Cancer | NCT00023842 | Bladder Cancer | BCG vaccine mitomycin C adjuvant therap... conventional su... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder | NCT02901548 | Carcinoma in Si... Bladder Cancer | Durvalumab Cystoscopy with... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer | NCT00002490 | Bladder Cancer | BCG vaccine mitomycin C radiation thera... | - | National Cancer Institute (NCI) | |
| The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer | NCT01697306 | Bladder Cancer | Gemcitabine 2 g BCG Vaccine | 18 Years - 85 Years | Azienda Ospedaliera San Giovanni Battista | |
| BCG With or Without Mitomycin in Treating Patients With Bladder Cancer | NCT00023842 | Bladder Cancer | BCG vaccine mitomycin C adjuvant therap... conventional su... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer | NCT00004122 | Bladder Cancer | BCG vaccine recombinant int... | 18 Years - | Roswell Park Cancer Institute | |
| BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer | NCT00352079 | Bladder Cancer | BCG vaccine gefitinib quality-of-life... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer | NCT00514072 | Prostate Cancer | BCG vaccine prostate cancer... placebo | 18 Years - | Kael-GemVax Co., Ltd. | |
| AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer | NCT00003759 | Bladder Cancer | BCG vaccine valrubicin conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | NCT00007826 | Colorectal Canc... | BCG vaccine monoclonal anti... alum adjuvant | 18 Years - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00006352 | Lung Cancer | BCG vaccine monoclonal anti... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer | NCT00003023 | Neuroblastoma Sarcoma | BCG vaccine monoclonal anti... | - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | NCT00016133 | Colorectal Canc... | BCG vaccine autologous tumo... fluorouracil leucovorin calc... adjuvant therap... | 21 Years - 85 Years | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
